Cargando…
Mechanism of Yangxin Tongmai Decoction in the Treatment of Coronary Heart Disease with Blood Stasis Syndrome Based on Network Pharmacology and Molecular Docking
This study aimed to explore the mechanism of Yangxin Tongmai decoction (YXTMD) in the treatment of coronary heart disease (CHD) with blood stasis syndrome (BSS) using network pharmacology and molecular docking, and to verify these results through clinical trials. The active compounds of YXTMD were i...
Autores principales: | Zhang, Mengxue, Liu, Jia, Zhang, Xiangzhuo, Zhang, Shumeng, Jiang, Yujie, Yu, Zixuan, Xie, Ting, Chen, Yuxia, Chen, Lingli, Li, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546682/ https://www.ncbi.nlm.nih.gov/pubmed/36212940 http://dx.doi.org/10.1155/2022/4692217 |
Ejemplares similares
-
Integrating Metabolomics and Network Pharmacology
to Explore the Mechanism of Tongmai Yangxin Pills in Ameliorating
Doxorubicin-Induced Cardiotoxicity
por: Shu, Lexin, et al.
Publicado: (2023) -
Tongmai Yangxin pill alleviates myocardial no-reflow by activating GPER to regulate HIF-1α signaling and downstream potassium channels
por: Chen, Ting, et al.
Publicado: (2023) -
Tongmai Yangxin intervening in myocardial remodeling after PCI for coronary heart disease: study protocol for a double-blind, randomized controlled trial
por: Wang, Yongxia, et al.
Publicado: (2020) -
Exploring the mechanism of Yizhi Tongmai decoction in the treatment of vascular dementia through network pharmacology and molecular docking
por: Shi, Hongshuo, et al.
Publicado: (2021) -
Clinical Effect of Tongmai Fuming Decoction on Neovascular Ophthalmopathy
por: Yang, Lei lei, et al.
Publicado: (2022)